about
Identification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of U.S.-based studies, 1996-2011.An intervention to reduce HIV risk behavior of substance-using men who have sex with men: a two-group randomized trial with a nonrandomized third groupEstimating the Population Sizes of Men Who Have Sex With Men in US States and Counties Using Data From the American Community Survey.Sexual risk of HIV transmission is missed by traditional methods of data collection.Social anxiety and HIV transmission risk among HIV-seropositive male patients.Is injection serosorting occurring among HIV-positive injection drug users? Comparison by injection partner's HIV statusSyndemic vulnerability, sexual and injection risk behaviors, and HIV continuum of care outcomes in HIV-positive injection drug users.Estimating the population size of men who have sex with men in the United States to obtain HIV and syphilis rates.HIV screening in the health care setting: status, barriers, and potential solutions.The Importance of Population Denominators for High-Impact Public Health for Marginalized Populations.NIH support of Centers for AIDS Research and Department of Health Collaborative Public Health Research: advancing CDC's Enhanced Comprehensive HIV Prevention Planning project.Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors.Incorporating couples-based approaches into HIV prevention for gay and bisexual men: opportunities and challenges.Opportunities for HIV combination prevention to reduce racial and ethnic health disparities.A review of the literature on event-level substance use and sexual risk behavior among men who have sex with men.A systematic review to identify challenges of demonstrating efficacy of HIV behavioral interventions for gay, bisexual, and other men who have sex with men (MSM).Depression and CD4 cell count among persons with HIV infection in Uganda.Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda.Desire for children and pregnancy risk behavior among HIV-infected men and women in Uganda.Agents of change: peer mentorship as HIV prevention among HIV-positive injection drug users.Sexual risk taking among HIV-positive injection drug users: contexts, characteristics, and implications for prevention.Partner awareness of the serostatus of HIV-seropositive men who have sex with men: impact on unprotected sexual behavior.Examining the role of partner status in an HIV prevention trial targeting HIV-positive gay and bisexual men: the seropositive urban men's intervention trial (SUMIT).Characteristics of bisexually active men in the Seropositive Urban Mens' Study (SUMS).Is sexual serosorting occurring among HIV-positive injection drug users? Comparison between those with HIV-positive partners only, HIV-negative partners only, and those with any partners of unknown status.Meta-analysis of cognitive-behavioral interventions on HIV-positive persons' mental health and immune functioning.Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users.Development, description, and acceptability of a small-group, behavioral intervention to prevent HIV and hepatitis C virus infections among young adult injection drug users.Recruitment source and behavioral risk patterns of HIV-positive men who have sex with men.Acceptability of A-CASI by HIV-positive IDUs in a multisite, randomized, controlled trial of behavioral intervention (INSPIRE).Correlates of lending needles/syringes among HIV-seropositive injection drug users.Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials.Correlates of risk patterns and race/ethnicity among HIV-positive men who have sex with men.Substance use and sexual transmission risk behavior of HIV-positive men who have sex with men.A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users.Estimating number of diagnosed persons living with HIV in the United States engaged in unprotected serodiscordant risk behavior with unsuppressed viral load.Predictors of current housing status among HIV-seropositive injection drug users (IDUs): results from a 1-year study.The life priorities of HIV-seropositive injection drug users: findings from a community-based sample.Beliefs about transmission risk and vulnerability, treatment adherence, and sexual risk behavior among a sample of HIV-positive men who have sex with men.The Bolger conference on PDE-5 inhibition and HIV risk: implications for health policy and prevention.
P50
Q27318276-DB75BAA8-AE1F-4AC4-8513-D80A73B0ACD0Q28475275-53A15A23-C6E8-4CBB-952D-54B21CBB79D1Q31102262-FCBCD774-5A3C-4C26-B034-94912101A990Q33201343-0821ECF9-E1D4-4F51-AE37-47B413D682C0Q34087815-B2956FFF-7722-4CEC-838D-C62CF0B795FDQ35597465-BCFE1E2C-356D-424E-9939-D2433897A579Q36257356-C155CE66-A2C9-47AB-B4E8-4ADE6737FF49Q36291903-6C3502D9-0A65-4B2C-B135-8F3AFC998A9CQ36513123-72434EAB-CECD-45D6-9227-B2634C580C0AQ36953088-0001745E-97D6-42F6-8F45-1A683F10A873Q37384124-5215649E-0211-4E11-9F6C-3574C7BBE567Q37550334-82DF8BCB-6726-4991-8D33-EEFAC5DBFFFCQ37572966-D6AC4EA1-3E24-40AA-B01D-1E689AF776B8Q37627361-DDB91394-8FD3-41D0-8C59-E86BC6DA0DACQ37983020-DDC917B8-EAB8-4713-8CFF-6BAE83F5D20CQ38080455-6B4894C7-9361-40B0-AACF-A0AB8D709E43Q38879319-09E7F3CF-FDDE-4626-B689-3B60DB01534EQ38879329-C01AB896-B4F1-42EC-8B58-08ECA731D885Q38879449-9EA8CD45-D2D7-4C66-920F-03820638C68EQ39639251-8A980042-2A7D-420D-9165-1DA879693BB3Q39714185-D77032E9-D3EF-4112-A4E1-5F849E97B04BQ39719112-82B33BD8-0B5B-42C6-812A-C5F6E283ED67Q39753933-4C1A225E-CC29-4F4D-B7DC-F3B39211A362Q39809609-E2A2C09D-7077-445C-B10C-7AC3EFA107CAQ39878816-99B9E62C-78E5-4430-BCEA-4A77A2B62470Q40129753-0C58E3C4-377B-460D-8974-3F300833E7E5Q40137766-335A7EEC-7813-43E8-A5EF-3F0926A294F4Q40218274-727C6DFA-A3B9-474C-9C06-401252E32FEDQ40318129-89A08DD6-7B6D-4606-A419-2BC4DC9F3487Q42640161-76488048-695F-4816-826F-5674EE8F9A11Q42640169-8CDF7CE8-C846-49F3-AD1F-8C547ADFCBBAQ42681632-6F929529-C3F3-4A53-9359-2F8E613523E5Q43587975-34853376-1E69-430A-BB67-2F1B2711F92FQ43628246-E4DCCB82-804B-4960-A42B-D50463CC18D0Q44109037-0FBBA1D2-704D-4D16-8031-26529D395D1DQ44169475-090E4439-B373-4F70-BF28-034523BD7DD1Q44255991-F36434A6-0621-48CD-81D4-8AAD951A4920Q44635316-FD5661A8-371A-433E-9DDB-25A81435FA29Q45244483-7D29C2AC-8345-418A-9A3C-7CACB6B5601AQ46061586-FEA2F263-083E-4A69-9654-3C0F1C443930
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David W. Purcell
@ast
David W. Purcell
@en
David W. Purcell
@es
David W. Purcell
@nl
David W. Purcell
@sl
type
label
David W. Purcell
@ast
David W. Purcell
@en
David W. Purcell
@es
David W. Purcell
@nl
David W. Purcell
@sl
altLabel
David Purcell
@en
prefLabel
David W. Purcell
@ast
David W. Purcell
@en
David W. Purcell
@es
David W. Purcell
@nl
David W. Purcell
@sl
P106
P1153
7006001913
P21
P31
P496
0000-0001-8125-5168